Jane Street’s Ambrx Biopharma Inc AMAM Stock Holding History

Jane Street’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,800	Closed	-$268K	–	10377
2023 Q4	$268K	Buy	18,800 +5,000	+36%	+$56.8K	﹤0.01%	7781
2023 Q3	$159K	Sell	13,800 -6,000	-30%	-$81.7K	﹤0.01%	7754
2023 Q2	$326K	Buy	+19,800	New	+$249K	﹤0.01%	6998
2023 Q1	–	Sell	-25,600	Closed	-$58.1K	–	10227
2022 Q4	$58.1K	Buy	+25,600	New	+$29.3K	﹤0.01%	8312

Jane Street's AMAM Position: Q1 2024 in Review

Jane Street sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 295,642 shares — an estimated $4.21M sold.

Jane Street first reported a position in AMAM in Q2 2023 and held it in 2 quarters. The position peaked at $4.21M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Jane Street reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Jane Street sold 295,642 Ambrx Biopharma Inc shares in Q1 2024, an estimated $4.21M.
Jane Street first reported a position in Ambrx Biopharma Inc in Q2 2023 and held it in 2 quarters.
Jane Street's Ambrx Biopharma Inc position peaked at $4.21M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.